» Articles » PMID: 38987406

Early Mutational Signatures and Transmissibility of SARS-CoV-2 Gamma and Lambda Variants in Chile

Abstract

Genomic surveillance (GS) programmes were crucial in identifying and quantifying the mutating patterns of SARS-CoV-2 during the COVID-19 pandemic. In this work, we develop a Bayesian framework to quantify the relative transmissibility of different variants tailored for regions with limited GS. We use it to study the relative transmissibility of SARS-CoV-2 variants in Chile. Among the 3443 SARS-CoV-2 genomes collected between January and June 2021, where sampling was designed to be representative, the Gamma (P.1), Lambda (C.37), Alpha (B.1.1.7), B.1.1.348, and B.1.1 lineages were predominant. We found that Lambda and Gamma variants' reproduction numbers were 5% (95% CI: [1%, 14%]) and 16% (95% CI: [11%, 21%]) larger than Alpha's, respectively. Besides, we observed a systematic mutation enrichment in the Spike gene for all circulating variants, which strongly correlated with variants' transmissibility during the studied period (r = 0.93, p-value = 0.025). We also characterised the mutational signatures of local samples and their evolution over time and with the progress of vaccination, comparing them with those of samples collected in other regions worldwide. Altogether, our work provides a reliable method for quantifying variant transmissibility under subsampling and emphasises the importance of continuous genomic surveillance.

Citing Articles

Molecular Epidemiology of SARS-CoV-2 during Five COVID-19 Waves and the Significance of Low-Frequency Lineages.

Subramoney K, Mtileni N, Giandhari J, Naidoo Y, Ramphal Y, Pillay S Viruses. 2023; 15(5).

PMID: 37243279 PMC: 10223853. DOI: 10.3390/v15051194.


The role of machine learning in health policies during the COVID-19 pandemic and in long COVID management.

Varon L, Gonzalez-Puelma J, Medina-Ortiz D, Aldridge J, Alvarez-Saravia D, Uribe-Paredes R Front Public Health. 2023; 11:1140353.

PMID: 37113165 PMC: 10126380. DOI: 10.3389/fpubh.2023.1140353.


Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences.

Hoteit R, Yassine H Vaccines (Basel). 2022; 10(6).

PMID: 35746526 PMC: 9230982. DOI: 10.3390/vaccines10060919.


Describing a landscape we are yet discovering.

Contreras S, Dehning J, Priesemann V Adv Stat Anal. 2022; 106(3):399-402.

PMID: 35698579 PMC: 9178930. DOI: 10.1007/s10182-022-00449-5.


Identification of the Gamma variant in an outbreak of COVID-19 at a prison in Peru.

Vargas-Herrera N, Roque de la Piedra S, Padilla-Rojas C, Yagui-Moscoso M Rev Esp Sanid Penit. 2022; 23(3):128-129.

PMID: 35411916 PMC: 8802818. DOI: 10.18176/resp.00042.


References
1.
Fraser C . Estimating individual and household reproduction numbers in an emerging epidemic. PLoS One. 2007; 2(8):e758. PMC: 1950082. DOI: 10.1371/journal.pone.0000758. View

2.
Thompson R, Hill E, Gog J . SARS-CoV-2 incidence and vaccine escape. Lancet Infect Dis. 2021; 21(7):913-914. PMC: 8043582. DOI: 10.1016/S1473-3099(21)00202-4. View

3.
Singh D, Yi S . On the origin and evolution of SARS-CoV-2. Exp Mol Med. 2021; 53(4):537-547. PMC: 8050477. DOI: 10.1038/s12276-021-00604-z. View

4.
Flaxman S, Mishra S, Gandy A, Unwin H, Mellan T, Coupland H . Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020; 584(7820):257-261. DOI: 10.1038/s41586-020-2405-7. View

5.
Dong E, Du H, Gardner L . An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020; 20(5):533-534. PMC: 7159018. DOI: 10.1016/S1473-3099(20)30120-1. View